Healix Executive and Leadership Team

Brit Pim, the Chief Executive Officer at Healix, directs the overarching strategic vision for physician office-based infusion services. By aligning clinical excellence with operational efficiency, the Chief Executive Officer ensures that medical practices maintain high standards of patient care. Pim oversees the expansion of infusion capabilities, focusing on long-term growth and market stability. This leadership role involves constant collaboration with the board to refine service delivery models that enhance physician peace of mind. Through rigorous oversight of national service standards, the Chief Executive Officer maintains the company's position as a leader in the outpatient infusion sector. By fostering a culture of compliance and quality, Brit Pim drives the organization toward sustainable success. The Chief Executive Officer continuously evaluates market trends to adapt service offerings, ensuring that every patient receives optimal care within the comfort of a physician-led environment.

Becky White-Steensma, the Chief Executive Officer & Founder at Healix, architects the foundational mission of providing superior office-based infusion solutions. As the visionary behind the organization, the Chief Executive Officer & Founder monitors the integration of patient-centric care models into diverse medical practices. White-Steensma drives the strategic direction of the company, ensuring that clinical outcomes remain the primary focus of all service offerings. This leadership role involves shaping the corporate culture to emphasize physician support and patient safety. By maintaining deep industry relationships, the Chief Executive Officer & Founder secures the company's reputation for excellence in the outpatient setting. Becky White-Steensma evaluates the efficacy of infusion programs, adjusting operational frameworks to meet evolving healthcare demands. Through consistent dedication to the original mission, the Chief Executive Officer & Founder guarantees that the organization remains at the forefront of infusion therapy innovation and clinical reliability.

Melisa Norton, the Chief Financial Officer at Healix, directs the fiscal strategy and financial health of the organization. By managing capital allocation and revenue cycles, the Chief Financial Officer ensures that the company maintains the resources necessary to support high-quality infusion services. Norton oversees budgeting, financial reporting, and long-term investment planning to sustain growth in the outpatient market. This leadership role involves analyzing economic trends to mitigate risks and identify new opportunities for financial expansion. By optimizing cost structures, the Chief Financial Officer supports the delivery of affordable, physician-led care. Melisa Norton collaborates with the executive team to ensure that financial objectives align with the company's mission of clinical excellence. Through precise financial oversight, the Chief Financial Officer provides the stability required for the organization to thrive. Norton maintains rigorous standards of fiscal accountability, ensuring that all operations remain profitable while upholding the highest levels of patient care.

Casey Lucas, the Chief Operating Officer & Executive VP, Sales at Healix, directs the daily operational workflows and national sales initiatives. By overseeing the implementation of infusion programs in physician offices, the Chief Operating Officer & Executive VP, Sales ensures that clinical standards are met consistently across all regions. Lucas manages the sales force to expand the company's footprint, focusing on building strong partnerships with medical practices. This leadership role involves streamlining service delivery to maximize efficiency and patient satisfaction. By coordinating between sales and operations, the Chief Operating Officer & Executive VP, Sales aligns market growth with the company's capacity to provide high-quality care. Casey Lucas evaluates operational performance metrics to drive continuous improvement in service delivery. Through strategic sales planning, the Chief Operating Officer & Executive VP, Sales secures the company's market position, ensuring that more physicians have access to reliable, office-based infusion solutions.

Mark Winters, the Partner, Executive Board Member, President at Healix, directs the high-level governance and corporate development of the organization. By serving on the board, the Partner, Executive Board Member, President shapes the long-term strategic direction and ensures alignment with the company's core mission. Winters oversees the execution of major corporate initiatives, focusing on expanding the reach of physician office-based infusion services. This leadership role involves fostering relationships with key stakeholders to drive organizational success and market influence. By providing executive oversight, the Partner, Executive Board Member, President ensures that all departments operate in harmony with the company's commitment to patient care. Mark Winters evaluates the overall performance of the organization, identifying opportunities for innovation and sustainable growth. Through active participation in board-level decision-making, the Partner, Executive Board Member, President secures the company's future as a leader in the outpatient infusion industry.

Tanishq Goyal, the Chief Technology Officer at Healix, directs the digital infrastructure supporting office-based infusion services. By implementing advanced software solutions, the Chief Technology Officer optimizes data management and clinical reporting for partner physicians. Goyal oversees the development of secure platforms that ensure patient information remains protected while facilitating seamless care coordination. This leadership role involves integrating new technologies to improve operational efficiency across all national service sites. By modernizing the technical stack, the Chief Technology Officer enables the organization to scale its infusion capabilities effectively. Tanishq Goyal collaborates with other executives to align digital initiatives with the company's broader clinical goals. Through the deployment of robust IT systems, the Chief Technology Officer enhances the overall user experience for both medical staff and patients. Goyal maintains a focus on technological agility, ensuring that the company remains competitive in a rapidly evolving healthcare landscape.

Tom Reinckens, the Chief Information & Procurement Officer at Healix, directs the supply chain logistics and information systems essential for infusion therapy. By managing the procurement of pharmaceuticals and medical supplies, the Chief Information & Procurement Officer ensures that partner physicians have the necessary resources for optimal patient care. Reinckens oversees the integration of inventory management systems with clinical data platforms to maintain high levels of compliance and efficiency. This leadership role involves negotiating vendor contracts to secure cost-effective access to critical medications. By streamlining the procurement process, the Chief Information & Procurement Officer supports the company's ability to provide reliable, office-based services. Tom Reinckens collaborates with the technology team to ensure that information systems support supply chain transparency. Through meticulous management of resources, the Chief Information & Procurement Officer guarantees that the organization maintains a consistent and high-quality supply of infusion products for all patients.

Blake Griese, the General Counsel & Head of Pharmacy at Healix, directs the legal framework and pharmaceutical operations of the company. By overseeing regulatory compliance and pharmacy standards, the General Counsel & Head of Pharmacy ensures that all infusion services adhere to strict healthcare laws. Griese manages the legal risks associated with outpatient care, providing guidance that protects both the company and its partner physicians. This leadership role involves supervising pharmacy operations to guarantee the safe and accurate preparation of infusion medications. By aligning legal requirements with clinical practices, the General Counsel & Head of Pharmacy maintains the integrity of the company's service model. Blake Griese collaborates with the executive team to navigate complex regulatory environments, ensuring that the organization remains compliant while pursuing growth. Through rigorous oversight of pharmacy protocols, the General Counsel & Head of Pharmacy upholds the highest standards of patient safety and clinical excellence.